Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
BlackRock, Inc. reports beneficial ownership of 8,860,866 shares of Life360, Inc. common stock, equal to 11.0% of the class. The filing states BlackRock has sole voting power for 8,789,461 shares and sole dispositive power for 8,860,866 shares. The filing identifies iShares Core S&P Small-Cap ETF as a holder with >5% interest.
Life360, Inc. director John Philip Coghlan reported an open-market sale of 4,000 shares of common stock at a weighted average price of $41.32 per share. The shares were sold by the John Coghlan Living Trust under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025.
After this sale, the John Coghlan Living Trust held 36,431 shares of Life360 common stock. Separate from the trust, Coghlan also reported 836 restricted stock units directly and 55,494 shares held indirectly through The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
Life360 director Alex Haro exercised stock options to acquire additional common shares. He exercised options covering 144,533 shares of Life360, Inc. common stock across three grants at exercise prices of $2.15, $8.19 and $13.35 per share. These exercises converted derivative awards into outright share ownership and left no remaining balance in the exercised option grants. Following the transactions, Haro directly owned 1,005,848 shares of common stock. This direct position includes 679 restricted stock units, each representing a right to receive one share of common stock upon vesting.
Life360, Inc. Chief Financial Officer Russell John Burke reported an equity award linked to performance-based restricted stock units. On March 25, 2026, a performance metric tied to PRSUs granted on April 9, 2025 was determined to be satisfied, triggering acquisition of 24,265 shares of common stock at no cost.
Each PRSU represents a right to receive one share upon settlement. According to the filing, 25% of these PRSUs vested on January 1, 2026, with the remaining 75% converted to time-based RSUs that will vest in twelve equal quarterly installments, subject to continued service. Following this and prior grants, Burke holds 80,838 restricted stock units directly and 113,361 shares indirectly through the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust ELD as tenants in common, reflecting both direct and trust-based ownership. The filing also notes an exempt transfer of 22,284 directly held shares into this trust structure.
Life360 director Chris Hulls reported an award of 54,595 shares of common stock tied to performance-based restricted stock units. The PRSUs were granted on April 9, 2025 and became reportable when the performance metric was determined to be met on March 25, 2026.
Each PRSU represents a right to receive one share of common stock upon settlement. Twenty-five percent vested on January 1, 2026, and the remaining 75% converted to time-based RSUs that vest in twelve equal quarterly installments, subject to continued service. After this award, Hulls directly holds 388,914 shares, and separate 2023 irrevocable trusts bearing family names each hold 195,312 shares as indirect positions.
Life360, Inc. Chief Executive Officer Lauren Antonoff reported an equity award tied to performance. She acquired 24,265 shares of common stock at no cost through performance-based restricted stock units after a performance metric was met. Following this grant, she directly holds 312,497 shares, including earlier restricted stock unit awards.
Life360 Inc — The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A disclosing that, after an internal realignment, the reporting parties formerly aggregated with Vanguard now report separately and the filing shows 0 shares beneficially owned and 0% of the class.
The amendment cites SEC Release No. 34-39538 (January 12, 1998) and states the holdings are reported in the form of depository receipts. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Life360, Inc. director Chris Hulls reported an option exercise and related share sale. He exercised stock options for 27,000 shares of common stock at an exercise price of $8.19 per share, then sold 15,133 shares of common stock at a weighted average price of $39.43 per share.
Following these transactions, Hulls directly holds 334,319 shares of common stock and also reports indirect holdings through 2023 irrevocable trusts. The filing notes that the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025, and that 108,371 restricted stock units are included in his reported holdings.
Life360, Inc. director Synge James reported a bona fide gift of 8,333 shares of common stock on March 17, 2026. The transfer was made for charitable purposes and involved no sale proceeds. After this gift, James holds 186,421 shares of common stock, including shares underlying Chess Depositary Interests and 703 restricted stock units.